Hi , Thank you to this week’s sponsor Culture Biosciences, who believe biomanufacturing hardware and software tools should be
faster, cheaper, and easier to use, and spend their days figuring out how to achieve that. Are you accurately tracking your fermentation process's inputs and outputs? If not, you risk developing a process that's not commercially viable. In this white paper, see data on how Culture's Cloud Bioreactors automatically track bioreactor inputs and outputs to ensure high-quality fermentation data.
Introducing Built with Biology Spotlight!
We say that biology is changing the future. But what progress have we made? What does it look like, feel like, even taste like?
Co-hosts Fiona Mischel and Nikita Michelsen highlight the game changers of the biology world: Who is building a better world with biology, how are they doing it, and when could it impact your life? Listen now to our first Spotlight: Checkerspot!
Psst: After you listen to the show, give @Checkerspot_ a shoutout and maybe help a certain Spotlight host score a pair of skis! They’ll never know what hit ‘em :)
Join us today for the Built with Biology show on Twitter Spaces at 8 am PT! Spaces is an audio-only platform—all you need is a Twitter handle and the Twitter app on your phone.
Today’s guests include Gigi Gronvall (Johns Hopkins Center for Health Security) and Megan Palmer (Bio Policy and Leadership Initiatives - Stanford)
Investors Bet Big with Fungi Alternative Protein Company Enough In a funding round led by Nutreco, a global producer of animal and fish feed, UK-based
startup ENOUGH (formerly 3F BIO) raised a £30 million Series B ($51 million) to bet on fungi as the alternative meat of the not-too-far future.
John Cumbers for Forbes
Collaborative Technology Is Making Drug Discovery Easier and Faster The pandemic showed the importance of quickly developing new therapeutics for a dangerous disease. Now, leading life sciences cloud company, Benchling, announced the launch of a new unified platform that supports the development of RNA-based treatments. The company’s new tools aim to break silos between chemistry and biology and bring novel therapeutics to patients with orphan diseases faster.
Science News
Nature Biotechnology asked a selection of leaders from across biotech, including John Cumbers, to look at the future of the sector and make some predictions for the coming years. What will be the most important developments in biotech business and its
contributions across the globe in the coming years?
Artificial proteins never seen in the natural world are becoming new COVID vaccines and medicines. Researchers have begun to crack the code of protein structure, allowing them to remake, well, everything.
Funding News
Motif FoodWorks, the food technology company on a mission to make plant-based food better tasting and more nutritious, has raised $226 million in Series B funding. Congratulations to CEO Jonathan McIntyre and the whole team!
Kytopen has been awarded an NIH grant of up to $2 million to unlock the power of engineered Natural Killer (NK) cells via the Flowfect® Platform.
HiFiBiO announced an oversubscribed $75 million series D to bring two lead antibody oncology programs into the clinic and further its COVID-19 antibody candidate.
